These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34424503)

  • 21. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
    Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
    Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
    Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
    Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
    Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
    Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.
    Aird KM; Li H; Xin F; Konstantinopoulos PA; Zhang R
    Cell Cycle; 2014; 13(2):199-207. PubMed ID: 24200970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features.
    Spagnolo E; Martinez A; Mascarós-Martínez A; Marí-Alexandre J; Carbonell M; González-Cantó E; Pena-Burgos EM; Mc Cormack BA; Tomás-Pérez S; Gilabert-Estellés J; López-Carrasco A; Hidalgo P; Ángeles MA; Redondo A; Gallego A; Hernández A
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
    Long L; Cao Y; Tang LD
    Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer.
    Nero C; Romito I; Spadola S; Romito A; Turco LC; Cosentino F; De Ninno M; Catena U; De Cicco Nardone A; Moroni R; Zannoni G; Fagotti A; Scambia G
    Fertil Steril; 2022 Jan; 117(1):160-168. PubMed ID: 34656305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transverse Relaxation Rate of Cyst Fluid Can Predict Malignant Transformation of Ovarian Endometriosis.
    Yoshimoto C; Takahama J; Iwabuchi T; Uchikoshi M; Shigetomi H; Kobayashi H
    Magn Reson Med Sci; 2017 Apr; 16(2):137-145. PubMed ID: 27646154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma.
    Chang CM; Wang ML; Lu KH; Yang YP; Juang CM; Wang PH; Hsu RJ; Yu MH; Chang CC
    Oncotarget; 2018 Jan; 9(3):3704-3726. PubMed ID: 29423077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of redox parameters in ovarian endometrioma and its malignant transformation.
    Fujimoto Y; Imanaka S; Yamada Y; Ogawa K; Ito F; Kawahara N; Yoshimoto C; Kobayashi H
    Oncol Lett; 2018 Oct; 16(4):5257-5264. PubMed ID: 30214615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.
    Murakami K; Kotani Y; Nakai H; Matsumura N
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
    del Carmen MG
    Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
    Del Carmen MG; Smith Sehdev AE; Fader AN; Zahurak ML; Richardson M; Fruehauf JP; Montz FJ; Bristow RE
    Cancer; 2003 Oct; 98(8):1658-63. PubMed ID: 14534882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation.
    Robinson KA; Menias CO; Chen L; Schiappacasse G; Shaaban AM; Caserta MP; Elsayes KM; VanBuren WM; Bolan CW
    Abdom Radiol (NY); 2020 Jun; 45(6):1762-1775. PubMed ID: 30941451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SiRNA-Mediated
    Xue T; Wang L; Li Y; Song H; Chu H; Yang H; Guo A; Jiao J
    Int J Med Sci; 2019; 16(11):1510-1516. PubMed ID: 31673243
    [No Abstract]   [Full Text] [Related]  

  • 36. Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer.
    Livori K; Calleja-Agius J
    Discov Med; 2024 Mar; 36(182):467-481. PubMed ID: 38531788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
    Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
    Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
    Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
    Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of risk models based on machine learning to predict endometriosis-associated ovarian cancer in patients with endometriosis.
    Chao X; Wang S; Lang J; Leng J; Fan Q
    Acta Obstet Gynecol Scand; 2022 Dec; 101(12):1440-1449. PubMed ID: 36210724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development.
    Yachida N; Yoshihara K; Yamaguchi M; Suda K; Tamura R; Enomoto T
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.